Eevia Health Plc Logo

Eevia Health Plc

Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.

EEVIA | SPGR

Overview

Corporate Details

ISIN(s):
FI4000496658
LEI:
743700NO7D0UA8J1MQ31
Country:
Finland
Address:
Koulukatu 14, FI-60100 SEINÄJOKI
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eevia Health Plc is a life science company specializing in the development and manufacturing of scientifically validated, high-concentration bioactive plant extracts. The company processes wild-harvested and organically farmed Arctic raw materials, such as berries, into standardized polyphenol extracts for the dietary supplement and food industries. Its product lines include 'Condition-Specific Bioactives' targeting gut, kidney, and urinary microbiome health, with research extending to eye and cognitive function. Eevia Health operates with a focus on sustainability through its 'Nordic Green Chemistry' manufacturing process, emphasizing its commitment to potent, excipient-free ingredients under its 'Dose Matters™' philosophy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Eevia Health Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Eevia Health Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-12 Stein Ulve Other Other 2,726,717 54,534.34 EUR

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780

Talk to a Data Expert

Have a question? We'll get back to you promptly.